WHO ICTRP trial
A phase II study with Tegafur/Uracil and Peg-Interferon after TACE for…
JPRN-C000000275 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-C000000275 |
|---|---|
| Public title | A phase II study with Tegafur/Uracil and Peg-Interferon after TACE for hepatocelluler carcinoma |
| Scientific title | A phase II study with Tegafur/Uracil and Peg-Interferon after TACE for hepatocelluler carcinoma - A phase II study with Tegafur/Uracil and Peg-Interferon after TACE for hepatocelluler carcinoma |
| Primary sponsor | The third department of Internal Medicine, Wakayama Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Advanced hepatocellular carcinoma |
| Interventions | Combination chemotherapy with Peg-Interferon and oral Tegafur/Uracil |
| Registration date | Feb 11, 2005 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: